Tower Research Capital (TRC)’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-293
Closed -$1.12K 5578
2024
Q4
$1.12K Sell
293
-366
-56% -$1.97K ﹤0.01% 5093
2024
Q3
$4.72K Buy
659
+411
+166% +$2.92K ﹤0.01% 4440
2024
Q2
$1.82K Hold
248
﹤0.01% 5087
2024
Q1
$2.48K Sell
248
-1,434
-85% -$12.6K ﹤0.01% 5028
2023
Q4
$11.8K Buy
1,682
+1,434
+578% +$9.53K ﹤0.01% 4099
2023
Q3
$1.97K Hold
248
﹤0.01% 5231
2023
Q2
$1.37K Hold
248
﹤0.01% 5394
2023
Q1
$1K Sell
248
-1
-0.4% -$7 ﹤0.01% 5579
2022
Q4
$2K Sell
249
-174
-41% -$1.79K ﹤0.01% 5393
2022
Q3
$4K Sell
423
-1,027
-71% -$11.9K ﹤0.01% 5274
2022
Q2
$15K Buy
1,450
+1,219
+528% +$18.1K ﹤0.01% 4079
2022
Q1
$5K Sell
231
-80
-26% -$1.75K ﹤0.01% 5076
2021
Q4
$8K Buy
+311
New +$8.59K ﹤0.01% 4806

Other funds holding MSOS

Tower Research Capital (TRC)'s MSOS Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2025, closing a stake of 293 shares — an estimated $1.12K sold.

Tower Research Capital (TRC) first reported a position in MSOS in Q4 2021 and held it in 13 quarters. The position peaked at $15K in Q2 2022. 157 funds tracked by Wall St. Rank hold MSOS as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 293 AdvisorShares Pure US Cannabis ETF shares in Q1 2025, an estimated $1.12K.
  • Tower Research Capital (TRC) first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s AdvisorShares Pure US Cannabis ETF position peaked at $15K in Q2 2022.
  • 157 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.